A little studied lesion, the resolving lesion, is described in multiple sclerosis (MS). Unusual features of early resolving lesions comprised a fibrous astrogliotic parenchyma replete with lipid-laden (foamy) microglia/macrophages widely scattered throughout and lined up at the edge, separating demyelinated plaque from myelinated white matter. Ongoing myelin breakdown was absent, as was remyelination. Later resolving lesions displayed the unusual coexistence of macrophages and remyelination within the gliotic parenchyma. Collectively, these observations may provide for the first time evidence for a role in MS for mitigating factors like alternatively-activated (M2) microglia/macrophages, known to have an anti-inflammatory phenotype and to be associated with wound-healing and repair.
Introduction
This overview will highlight structural events, some of them novel, occurring at the margins of the resolving lesion in multiple sclerosis (MS) . From a neuropathologic standpoint, two long-pondered questions are posed: first, why does the typical MS plaque have a sharp edge?; and second, why does the plaque not progress relentlessly throughout the central nervous system (CNS)? Through the eyes of the resolving lesion, this overview will engage these questions, notwithstanding that they have already been addressed to some extent in the literature in studies which concluded that events at the lesion edge were related to astroglial scarring and/or oligodendroglial responses. However, when framed against current opinions on lesion pathogenesis and macrophage dynamics, such explanations appear inadequate. In this regard, this account will break the mold and propose that in addition to glial cells, activated microglia/macrophages (currently a hotbutton topic in neuroimmunology), a prominent feature in resolving lesions, play seminal roles and may orchestrate reparatory and regulatory functions.
Results
For fuller coverage of the pathology associated with the spectrum of lesion types and stages in MS, a major chronic debilitating neurologic condition of young adults, the reader is referred to the classic accounts of Adams and Sidman (1968), Lumsden (1970) , and Greenfield and Norman (1971) Prineas et al. (1993a) on CNS remyelination in nascent MS lesions did mention them briefly. For the purposes of the present discourse, drawn from early autopsy and biopsy CNS tissue from cases of acute and primary progressive MS, it might be helpful to the reader to reiterate the salient features of acute and chronic MS lesions for comparison with the more transient resolving lesion. In the acute MS lesion, the edge is broad and indistinct as demyelinated CNS parenchyma transitions gradually into normal-appearing white matter (NAWM) - Fig. 1A . This zone, as well as most of the body of the lesion, is heavily infiltrated perivascularly and parenchymally by hematogenous cells (small lymphocytes, plasma cells and monocytes), the phenotypic analysis of which has been extensively investigated -see Ludwin and Raine (2008) , inter alia. At the other end of the spectrum, the demyelinated, chronic (silent) MS lesion has a sharp edge, is strikingly less cellular, is composed mainly of fibrous astrocytes and microglia, is essentially free of cellular infiltration, and stands out prominently from NAWM (Fig. 1B) .
Resolving lesions arise within or adjacent to late-stage acute lesions and in areas of recent activity related to chronic lesions (usually in cases of primary progressive MS), by which time, active demyelination has subsided and infiltrating hematogenous cells have departed, leaving in their place an homogeneous population of foamy microglia/
